TPD52 and neoplasm: Aberrant expression of TPD52 (encoding TPD52) has been reported in a wide range of cancers, including BrCa, and several tumor‐suppressive miRNA have been reported to be involved in regulating the expression of these genes (Balleine et al., 2000; Byrne et al., 2014; Li et al., 2016; Roslan et al., 2014).